UFT inhibits lung metastases in spontaneous metastasis model of lung cancer

Thoracic and Cardiovascular Surgeon

Volumn 53, Issue 2, 2005, Pages 118-121

  Miyahara, R ^a   Nakagawa, T ^a   Ishikawa, S ^a   Fukushima, M ^b   Wada, H ^a   Tanaka, Fumihiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Metastasis; Mouse model; Non small cell lung cancer; UFT

Indexed keywords

4 HYDROXYBUTYRIC ACID; SODIUM CHLORIDE; TEGAFUR; UFT; URACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CANCER SURGERY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; FOOT PAD; LEWIS CARCINOMA; LUNG METASTASIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; METASTASIS INHIBITION; MOUSE; MOUSE STRAIN; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CARCINOMA, NON-SMALL-CELL LUNG; DRUG COMBINATIONS; HUMANS; HYDROXYBUTYRATES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; TEGAFUR; URACIL;

EID: 17444374580     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830361     Document Type: Article

References (12)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 116: 1710-1717
2. Tanaka F, Yanagihara K, Otake Y et al. Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend. Eur J Cardiothorac Surg 2000; 18: 147-155
3. Wada H, Hitomi S, Teramatsu T et al. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncol 1996; 14: 1046-1054
4. Wada H, Miyahara R, Tanaka F et al. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegafur) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Surgery Group for Lung Cancer Surgery (WJSG). Eur J Cardiothorac Surg 1999; 15: 438-443
5. The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu Japan). A randomized trial of post operative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). Eur J Surg Oncol 1995; 21: 69-77
6. Kato H, Tsuboi M, Ohta M et al. A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I (T1N0M0, T2N0N0) adenocarcinoma of the lung. Proc ASCO 2003; 22: 621 (abstr. #2498)
7. Fujii S, Ikenaka K, Fukushima M et al. Effect of Uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5- fluorouracil. Gann (Jpn J Cancer Res) 1978; 69: 763-772
8. Yonekura K, Basaki Y, Chikahisa L et al. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clin Cancer Res 1999; 5: 2185-2191
9. Basaki Y, Chikahisa L, Aoyagi K et al. Gamma-hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. Angiogenesis 2001; 4: 163-173
10. Uchida J, Sato K, Okabe H et al. Experimental postoperative adjuvant chemotherapy by UFT using primary tumor amputation model. Int J Molecular Medicine 2000; 5: 357-362
11. Fujita F, Fujita M, Shimozuma K et al. Analysis of factors influencing the chemosensitivity of human tumors xenografted into nude mice. Jpn J Cancer Chemother 1986; 13: 3221-3228
12. Nio Y, Kimura H, Tsubono M et al. A comparative study of anti tumor activities of 5′-deoxy-5-fluorouridine and its prodrug trimetoxy benzoyl-5′-deoxy-5-fluorouridine (Ro09 1390) on human digestive organ cancer xenograft lines transplanted into nude mice. Anti cancer Drugs 1992; 3: 387-393